We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
An image displaying a Newsletter on tablet, laptop & mobile

To continue reading this article, sign up for FREE to

Technology Networks logo


Membership is FREE and provides you with instant access to email newsletters, digital publications, our full content catalogue & more...

New Ready-to-use Lentivirus Supernatant

Read time: Less than a minute
AMSBIO have announced a range of ready-to-use lentivirus supernatant products suitable for many kinds of gene delivery applications including mammalian protein expression, stable cell line construction, cell signal pathway localization and stem cell research.

Prepared using proprietary protocols to integrate a real-time fluorescence monitoring tag in the system - each 200ml vial of AMSBIO lentivirus supernatent contains a high titre of highly transducible lentivirus (1 x 10 e7 IFU/ml).

Each vial of lentiviral supernatent particles contains a fully sequence verified target, ready for transduction into any mammalian cells. All AMSBIO lentivirus supernatent products are easy and safe to use, simply add 50ul into the cultured cells, and you will be able to confirm the specific target's expression under a fluorescent microscope after 48-72 hours.

The AMSBIO lentiviral system is a gene delivery tool using lentivectors for gene expression or knockdown. Lentivirus can effectively transduce both dividing and non-dividing mammalian cells, and integrate into the host genome, allowing stable long-term, high-level gene expression both in vivo and in vitro.
Google News Preferred Source Add Technology Networks as a preferred Google source to see more of our trusted coverage.